BR9800718A - Composto esteróide composição farmacéutica uso de um composto esteróide e processo para a preparação de um estróide - Google Patents

Composto esteróide composição farmacéutica uso de um composto esteróide e processo para a preparação de um estróide

Info

Publication number
BR9800718A
BR9800718A BR9800718A BR9800718A BR9800718A BR 9800718 A BR9800718 A BR 9800718A BR 9800718 A BR9800718 A BR 9800718A BR 9800718 A BR9800718 A BR 9800718A BR 9800718 A BR9800718 A BR 9800718A
Authority
BR
Brazil
Prior art keywords
steroid
preparation
pharmaceutical composition
steroid compound
compound
Prior art date
Application number
BR9800718A
Other languages
English (en)
Other versions
BR9800718B1 (pt
Inventor
Hubert Jan Jozef Loozen
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BR9800718A publication Critical patent/BR9800718A/pt
Publication of BR9800718B1 publication Critical patent/BR9800718B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI9800718-1A 1997-02-21 1998-02-20 composto esteróide tendo atividade contraceptiva, anti-osteoporose e para prevenir e tratar queixas da menopausa, composição farmacêutica, uso de um composto esteróide, e, processo para a preparação de um esteróide 16, 17 anelado. BR9800718B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97102884 1997-02-21

Publications (2)

Publication Number Publication Date
BR9800718A true BR9800718A (pt) 1999-06-29
BR9800718B1 BR9800718B1 (pt) 2009-08-11

Family

ID=8226513

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9800718-1A BR9800718B1 (pt) 1997-02-21 1998-02-20 composto esteróide tendo atividade contraceptiva, anti-osteoporose e para prevenir e tratar queixas da menopausa, composição farmacêutica, uso de um composto esteróide, e, processo para a preparação de um esteróide 16, 17 anelado.

Country Status (27)

Country Link
US (2) US6077873A (pt)
EP (1) EP0869132B1 (pt)
JP (1) JP4392066B2 (pt)
KR (1) KR19980071540A (pt)
CN (2) CN100522984C (pt)
AR (1) AR011680A1 (pt)
AT (1) ATE205217T1 (pt)
AU (1) AU723713B2 (pt)
BR (1) BR9800718B1 (pt)
CA (1) CA2229960C (pt)
CZ (1) CZ50598A3 (pt)
DE (1) DE69801539T2 (pt)
DK (1) DK0869132T3 (pt)
ES (1) ES2164400T3 (pt)
HK (1) HK1016188A1 (pt)
HU (1) HU223755B1 (pt)
ID (1) ID19947A (pt)
IL (1) IL123195A (pt)
NO (1) NO310724B1 (pt)
NZ (1) NZ329789A (pt)
PL (1) PL188079B1 (pt)
PT (1) PT869132E (pt)
RU (1) RU2182153C2 (pt)
SG (1) SG60203A1 (pt)
TR (1) TR199800282A1 (pt)
TW (1) TW403736B (pt)
ZA (1) ZA981344B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW403736B (en) * 1997-02-21 2000-09-01 Akzo Nobel Nv Steroid compounds having contraceptive and anti-osteoporosis activity
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
ES2204613T3 (es) * 1999-04-06 2004-05-01 Akzo Nobel N.V. Androgenos 7-alfa alquilo oralmente activos.
CO5271709A1 (es) 2000-01-12 2003-04-30 Pfizer Prod Inc Composiciones y procedimientos para el y tratamiento de afecciones que responden a estrogenos
TWI225068B (en) * 2000-06-06 2004-12-11 Akzo Nobel Nv Anellated steroid compounds having contraceptive and anti-osteoporosis activity
JP2002241395A (ja) * 2001-02-16 2002-08-28 Taiho Yakuhin Kogyo Kk エストラ−４，６−ジエン−３，１７−ジオンの製造方法
US7250289B2 (en) 2002-11-20 2007-07-31 Affymetrix, Inc. Methods of genetic analysis of mouse
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
EP2127656A4 (en) * 2006-12-20 2010-03-03 Landsteiner Scient S A De C V COMPOSITIONS OF RISEDRONATE AND VITAMIN D3
TW201109346A (en) * 2009-06-10 2011-03-16 Organon Nv Substituted 16,17-annellated steroid compounds for use in women's healthcare
US8367648B2 (en) 2009-06-10 2013-02-05 Msd Oss B.V. Substituted 16,17-annellated steroid compounds for use in womens healthcare

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991001958A2 (de) * 1989-08-04 1991-02-21 Schering Aktiengesellschaft Berlin Und Bergkamen 11β-ARYL-GONA-4,9-DIEN-3-ONE
ATE105299T1 (de) * 1989-08-04 1994-05-15 Schering Ag 11 beta-substituierte 16 alpha, 17alpha-methylen- estra-4,9-dien-3-one.
US5407928A (en) * 1990-08-15 1995-04-18 Schering Aktiengesellschaft 11β-aryl-gona-4,9-dien-3-ones
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
TW403736B (en) * 1997-02-21 2000-09-01 Akzo Nobel Nv Steroid compounds having contraceptive and anti-osteoporosis activity

Also Published As

Publication number Publication date
PL324939A1 (en) 1998-08-31
PL188079B1 (pl) 2004-12-31
KR19980071540A (ko) 1998-10-26
CZ50598A3 (cs) 1998-09-16
HU223755B1 (hu) 2005-01-28
TW403736B (en) 2000-09-01
ES2164400T3 (es) 2002-02-16
CN1197076A (zh) 1998-10-28
HUP9800373A2 (hu) 1998-11-30
HU9800373D0 (en) 1998-04-28
IL123195A0 (en) 1998-09-24
EP0869132B1 (en) 2001-09-05
AR011680A1 (es) 2000-08-30
CA2229960C (en) 2007-12-18
CN101092442A (zh) 2007-12-26
DK0869132T3 (da) 2002-01-07
CN100522984C (zh) 2009-08-05
BR9800718B1 (pt) 2009-08-11
DE69801539T2 (de) 2002-04-18
TR199800282A1 (xx) 1998-09-21
NZ329789A (en) 1999-09-29
SG60203A1 (en) 1999-02-22
NO980737L (no) 1998-08-24
ATE205217T1 (de) 2001-09-15
HK1016188A1 (en) 1999-10-29
NO310724B1 (no) 2001-08-20
ZA981344B (en) 1998-08-27
IL123195A (en) 2002-11-10
NO980737D0 (no) 1998-02-20
CA2229960A1 (en) 1998-08-21
US6313180B1 (en) 2001-11-06
HUP9800373A3 (en) 1999-06-28
AU723713B2 (en) 2000-09-07
RU2182153C2 (ru) 2002-05-10
AU5541298A (en) 1998-08-27
EP0869132A1 (en) 1998-10-07
JPH10273499A (ja) 1998-10-13
PT869132E (pt) 2002-01-30
DE69801539D1 (de) 2001-10-11
ID19947A (id) 1998-08-27
MX9801428A (es) 1998-12-31
US6077873A (en) 2000-06-20
JP4392066B2 (ja) 2009-12-24

Similar Documents

Publication Publication Date Title
BR9602705A (pt) Composto composição farmacéutica processo para a preparação de um composto e uso
BR9505107A (pt) Composto composiçao farmacêutica processo para a preparaçao de um composto e seu uso
BR9501770A (pt) Uso de um composto,composto,formulação farmacêutica e processo para preparar um composto
BR9600821A (pt) Composto formulação farmacêutica e processo para a preparação de um composto
BR1100323A (pt) Composto, uso de um composto, composição farmacêutica e processo para preparar um composto
BR9609701A (pt) Composição farmacéutica composto e processo para a preparação de compostos
BR9611986A (pt) Compostos processo para a preparação dos mesmos composição farmcéutica e utilização dos compostos
BR9808422B1 (pt) composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
BR1100850A (pt) Composto, processo para a preparação de um composto, e, composição farmacêutica
BR9609780A (pt) Composto uso de um composto processo para o tratamento de condições composição farmacêutica processos para preparar uma composição farmacêutica e para preparar um composto
BR9807814B1 (pt) composto de pirazina, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
BR9610988A (pt) Composto uso do mesmo fomulação farmacêutica e processo para produção do composto
BR9600926A (pt) Micelas mistas composições aquosas processo para a preparação de micelas mistas e uso
BR9600930A (pt) Derivados de n-(3-benzofuranil)uréia processo para sua preparação composição processo para a preparação de composições e uso
BR9605354A (pt) Composto composição farmacêutica processo para a produção do composto e uso
BR9708014A (pt) Derivados de arilglicinamida processo para a preparação deles e composições farmacêuticas contendo estes compostos
BR9602922A (pt) Composição mistura estabilizadora uso e processo para a preparação de um polímero
BR9711311A (pt) Composto composi-Æo farmac-utica uso de um composto e processos para a prepara-Æo de compostos e para tratamento de um mamifero incluindo o homem
BR9509849A (pt) Composições cosmética processo para a preparação de mesma e uso de um material
BR9711340A (pt) Composto composi-Æo farmac-utica e processo para preparar um composto
BR9600339A (pt) Compostos composições farmacêuticas processo para a preparação de um composto e uso dos mesmos
BR9800718A (pt) Composto esteróide composição farmacéutica uso de um composto esteróide e processo para a preparação de um estróide
BR9602025A (pt) Composto composição farmacêutica uso e processo para a preparação de um composto
BR9607264A (pt) Composto derivado do isotiuréia composição farmacêutica uso de tal composto e processo para a preparação dos mesmos
BR9708790A (pt) Composto uso de um composto e formulação farmacêutica

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: N.V. ORGANON (NL)

Free format text: TRANSFERIDO DE: AKZO NOBEL N.V.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/08/2009, OBSERVADAS AS CONDICOES LEGAIS.

B24H Lapse because of non-payment of annual fees (definitively: art 78 iv lpi)
B24F Patent annual fee: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2259 DE 22/04/2014 POR TER SIDO INDEVIDA.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AS 14A, 15A, 16A, 17A, 18A, 19A, 20A, 21A E 22A ANUIDADES.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2607 DE 22-12-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.